It’s an issue at the intersection of money, health care, and politics. The FDA is considering making certain prescription drugs available over-the-counter, according to Bloomberg News. The drugs under consideration [...]
Lipitor loses patent, but will the mighty Pfizer crumble?
by ,
November 30, 2011, 11:29 AM
1November 30, 2011, 11:29 AM
Yes, today is the day. Lipitor’s patent has officially expired, marking the largest patent loss to date and bringing unavoidable changes to top drugmaker Pfizer’s revenue base. Watson Pharmaceuticals takes [...]
FDA approves skin cancer drug, personalized medicine advances
by ,
August 18, 2011, 3:46 PM
0August 18, 2011, 3:46 PM
Personalized medicine scored a point this week when the FDA granted early approval for Zelboraf, a biotech drug that aims to treat metastatic melanoma patients with certain genetic traits. The approval of Zelboraf, [...]
Smoking Cessation Drug Chantix May Increase Heart Disease
by ,
August 1, 2011, 1:29 PM
0August 1, 2011, 1:29 PM
You may have heard in the news recently that people trying to quit smoking may actually be increasing their risk for heart problems – if they’re taking Chantix, that is. [...]
FDA approvals: Pfizer’s R&D pipeline wins some and loses some
by ,
June 24, 2011, 2:51 PM
0June 24, 2011, 2:51 PM
Pfizer, whose precarious perch on top of the drugmaking heap depends on whether it can replace blockbuster drug Lipitor with new popular products, is making some headway in its drug [...]
Pfizer’s ‘virtual’ drug trial could reshape R&D processes
by ,
June 9, 2011, 11:52 AM
0June 9, 2011, 11:52 AM
Ever thought about answering one of those “Do you suffer from migraines?” or “Got bunions?” clinical trial ads, but just haven’t had the time or energy to enroll? Well, your [...]
Generics take over prescription market, causing overall drug spending to slow
by ,
April 22, 2011, 11:27 AM
0April 22, 2011, 11:27 AM
Doctors and pharmacists are increasingly writing and filling prescriptions for generic drugs — while scripts for patent-protected pharmaceuticals are declining — according to a study released this week by the [...]
New antibiotics urgently needed to kill “Superbugs”
by ,
April 8, 2011, 1:38 PM
0April 8, 2011, 1:38 PM
The World Health Organization has issued a cry for the development of new antibiotics to attack a growing class of amazingly strong drug-resistant bacteria, dubbed “superbugs,” but the marketplace for [...]
Pfizer divests Capsugel, but will a breakup tame the Lipitor dragon?
by ,
April 6, 2011, 1:37 PM
0April 6, 2011, 1:37 PM
Just a few weeks after CEO Ian Read roused speculation that Pfizer might reverse its long-term philosophy of “bigger is better” – a mantra near and dear to former CEO Jeff [...]
Needle-free insulin still a long shot for Mannkind
by ,
January 21, 2011, 5:12 PM
3January 21, 2011, 5:12 PM
Despite numerous trials and tribulations, Mannkind Corporation keeps holding on to the dream of making insulin shots for diabetes patients a thing of the past. In fact, the company, which [...]
Recent Comments